ArticleMolecular biotechnology2007

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia.

Stephen D Griffiths et al.PubMed ↗Publisher ↗

No numbers read from the abstract.